Thymoquinone inhibits lipopolysaccharide-induced inflammatory mediators in BV2 microglial cells

Yanan Wang(Qingdao University), Liqun Fang(Harbin Medical University), Wenjie Zhang(Shanghai Jiao Tong University), Weina Zhang(Fourth Affiliated Hospital of Harbin Medical University), Hongmei Gao(Harbin Medical University)
International Immunopharmacology
April 2, 2015
10.1016/j.intimp.2015.03.013
Cited by 51

Related Papers

Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease
|Journal of Neuropathology & Experimental Neurology|1999|232
Stability Issues in Electrochemical CO<sub>2</sub> Reduction: Recent Advances in Fundamental Understanding and Design Strategies
|Advanced Materials|2023|209
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|175
Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation
|ACS Nano|2020|170
In-situ doping of a conductive hydrogel with low protein absorption and bacterial adhesion for electrical stimulation of chronic wounds
|Acta Biomaterialia|2019|138